Visualitza per autor "Vahdat, Linda T."
Ara mostrant els elements 1-1 d 1
-
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study
Vahdat, Linda T.; Forero-Torres, Andres; Blackwell, Kimberly; Telli, Melinda L.; Melisko, Michelle; Cortés Castan, Javier; Schmid, Peter (Nature Research, 2021-05-20)